标题
The therapeutic potential of apelin in kidney disease
作者
关键词
-
出版物
Nature Reviews Nephrology
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-08-13
DOI
10.1038/s41581-021-00461-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2020) Boris Bikbov et al. LANCET
- Elabela/Toddler and apelin bind differently to the apelin receptor
- (2020) Pierre Couvineau et al. FASEB JOURNAL
- Cardiovascular response to small-molecule APJ activation
- (2020) Brandon Ason et al. JCI Insight
- ELA/APELA precursor cleaved by furin displays tumor suppressor function in renal cell carcinoma through mTORC1 activation
- (2020) Fabienne Soulet et al. JCI Insight
- Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion
- (2020) Donald J. Benton et al. NATURE
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apelin increases atrial conduction velocity, refractoriness, and prevents inducibility of atrial fibrillation
- (2020) Young M. Kim et al. JCI Insight
- Plasma kallikrein cleaves and inactivates apelin-17: Palmitoyl- and PEG-extended apelin-17 analogs as metabolically stable blood pressure-lowering agents
- (2019) Conrad Fischer et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Loss of Apelin Augments Angiotensin II-Induced Cardiac Dysfunction and Pathological Remodeling
- (2019) Teruki Sato et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting APLN/APLNR improves anti-angiogenic efficiency and blunts pro-invasive side effects of VEGFA/VEGFR2-blockade in glioblastoma
- (2019) Giorgia Mastrella et al. CANCER RESEARCH
- Apelin and apelin receptor expression in renal cell carcinoma
- (2019) Yuri Tolkach et al. BRITISH JOURNAL OF CANCER
- Apelin peptides linked to anti‐serum albumin domain antibodies retain affinity in vitro and are efficacious receptor agonists in vivo
- (2019) Cai Read et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders
- (2019) Eric Marsault et al. Annals of the New York Academy of Sciences
- Apelin inhibition prevents resistance and metastasis associated with anti‐angiogenic therapy
- (2019) Iris Uribesalgo et al. EMBO Molecular Medicine
- Apelin protects against abdominal aortic aneurysm and the therapeutic role of neutral endopeptidase resistant apelin analogs
- (2019) Wang Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand
- (2019) Cai Read et al. PHARMACOLOGICAL REVIEWS
- Apelin directs endothelial cell differentiation and vascular repair following immune-mediated injury
- (2019) Andrew G. Masoud et al. JOURNAL OF CLINICAL INVESTIGATION
- Remote Ischemic Perconditioning Modulates Apelin Expression After Renal Ischemia-Reperfusion Injury
- (2019) Firouzeh Gholampour et al. JOURNAL OF SURGICAL RESEARCH
- Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation
- (2019) Shankar Kumar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G protein biased ligands at the apelin receptor
- (2019) Duuamene Nyimanu et al. PEPTIDES
- Chronic treatment with apelin, losartan and their combination reduces myocardial infarct size and improves cardiac mechanical function
- (2019) Elham Abbasloo et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Development and validation of an LC-MS/MS method for detection and quantification of in vivo derived metabolites of [Pyr1]apelin-13 in humans
- (2019) Duuamene Nyimanu et al. Scientific Reports
- Associations Between Kidney Disease Measures and Regional Pulse Wave Velocity in a Large Community-Based Cohort: The Atherosclerosis Risk in Communities (ARIC) Study
- (2018) Esther D. Kim et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Apelin impairs myogenic response to induce diabetic nephropathy in mice
- (2018) Jia Zhang et al. FASEB JOURNAL
- Mechanisms of signalling and biased agonism in G protein-coupled receptors
- (2018) Denise Wootten et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The apelin/APJ system as a therapeutic target in metabolic diseases
- (2018) Isabelle Castan-Laurell et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure
- (2018) Emily J. See et al. KIDNEY INTERNATIONAL
- Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure
- (2018) Eric J. Velazquez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Involvement of Apelin/APJ Axis in Thrombogenesis in Valve Heart Disease Patients with Atrial Fibrillation
- (2018) Hai Cheng et al. International Heart Journal
- Apelin Is a Negative Regulator of Angiotensin II–Mediated Adverse Myocardial Remodeling and DysfunctionNovelty and Significance
- (2017) Zhen-Zhou Zhang et al. HYPERTENSION
- Synthetic Modification within the “RPRL” Region of Apelin Peptides: Impact on Cardiovascular Activity and Stability to Neprilysin and Plasma Degradation
- (2017) Shaun M. K. McKinnie et al. JOURNAL OF MEDICINAL CHEMISTRY
- ELABELA and an ELABELA Fragment Protect against AKI
- (2017) Hong Chen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effects of Intensive BP Control in CKD
- (2017) Alfred K. Cheung et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Chronic Kidney Disease
- (2017) Angela C Webster et al. LANCET
- Identification of essential genes for cancer immunotherapy
- (2017) Shashank J. Patel et al. NATURE
- Expression and functional implications of the renal apelinergic system in rodents
- (2017) Anne-Marie O’Carroll et al. PLoS One
- Structural Basis for Apelin Control of the Human Apelin Receptor
- (2017) Yingli Ma et al. STRUCTURE
- Protective Role of Apelin Against Cyclosporine-Induced Renal Tubular Injury in Rats
- (2017) J.S. Kim et al. TRANSPLANTATION PROCEEDINGS
- Apelin involved in progression of diabetic nephropathy by inhibiting autophagy in podocytes
- (2017) Yu Liu et al. Cell Death & Disease
- Loss of Apela Peptide in Mice Causes Low Penetrance Embryonic Lethality and Defects in Early Mesodermal Derivatives
- (2017) Laina Freyer et al. Cell Reports
- Apelin Plasma Levels Predict Arrhythmia Recurrence in Patients with Persistent Atrial Fibrillation
- (2017) C. Falcone et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Cardiac action of the first G protein biased small molecule apelin agonist
- (2016) Cai Read et al. BIOCHEMICAL PHARMACOLOGY
- The Metalloprotease Neprilysin Degrades and Inactivates Apelin Peptides
- (2016) Shaun M. K. McKinnie et al. CHEMBIOCHEM
- Angiotensin-Converting Enzyme 2 Metabolizes and Partially Inactivates Pyr-Apelin-13 and Apelin-17Novelty and Significance
- (2016) Wang Wang et al. HYPERTENSION
- Plasma Apelin Concentrations in Patients With Polyuria-Polydipsia Syndrome
- (2016) Sandrine Andrea Urwyler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Discovery and Structure–Activity Relationship of a Bioactive Fragment of ELABELA that Modulates Vascular and Cardiac Functions
- (2016) Alexandre Murza et al. JOURNAL OF MEDICINAL CHEMISTRY
- Agonist-induced internalization and desensitization of the apelin receptor
- (2016) George R. Pope et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Apelin/APJ system as a therapeutic target in diabetes and its complications
- (2016) Haoliang Hu et al. MOLECULAR GENETICS AND METABOLISM
- Evaluation of Fibrosis Markers: Apelin and Transforming Growth Factor-β1 in Autosomal Dominant Polycystic Kidney Disease Patients
- (2016) Derya Kocer et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heart
- (2015) Ábel Perjés et al. BASIC RESEARCH IN CARDIOLOGY
- Apelin protects against acute renal injury by inhibiting TGF-β1
- (2015) Hong Chen et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Apelin: an antithrombotic factor that inhibits platelet function
- (2015) F. Adam et al. BLOOD
- New structural insights into the apelin receptor: identification of key residues for apelin binding
- (2015) Romain Gerbier et al. FASEB JOURNAL
- Design, Characterization, and First-In-Human Study of the Vascular Actions of a Novel Biased Apelin Receptor Agonist
- (2015) A. L. Brame et al. HYPERTENSION
- Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study
- (2015) Eric A. J. Hoste et al. INTENSIVE CARE MEDICINE
- Apela Regulates Fluid Homeostasis by Binding to the APJ Receptor to Activate Gi Signaling
- (2015) Cheng Deng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Apelin promotes diabetic nephropathy by inducing podocyte dysfunction via inhibiting proteasome activities
- (2015) Caixia Guo et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Apelin and energy metabolism
- (2015) Chantal Bertrand et al. Frontiers in Physiology
- Elabela-Apelin Receptor Signaling Pathway is Functional in Mammalian Systems
- (2015) Zhi Wang et al. Scientific Reports
- The regulatory peptide apelin: a novel inhibitor of renal interstitial fibrosis
- (2014) Li-Yan Wang et al. AMINO ACIDS
- Identifying structural determinants of potency for analogs of apelin-13: Integration of C-terminal truncation with structure–activity
- (2014) Yanyan Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Stability and degradation patterns of chemically modified analogs of apelin-13 in plasma and cerebrospinal fluid
- (2014) Alexandre Murza et al. BIOPOLYMERS
- Apelin Counteracts Vasopressin-Induced Water Reabsorption via Cross Talk Between Apelin and Vasopressin Receptor Signaling Pathways in the Rat Collecting Duct
- (2014) Annette Hus-Citharel et al. ENDOCRINOLOGY
- The association between apelin-12 levels and paroxysmal supraventricular tachycardia
- (2014) Mehtap Gurger et al. Journal of Cardiovascular Medicine
- Apelin Increases Cardiac Contractility via Protein Kinase Cε- and Extracellular Signal-Regulated Kinase-Dependent Mechanisms
- (2014) Ábel Perjés et al. PLoS One
- Toddler: An Embryonic Signal That Promotes Cell Movement via Apelin Receptors
- (2014) A. Pauli et al. SCIENCE
- Pyroglutamyl apelin-13 identified as the major apelin isoform in human plasma
- (2013) Eugene Y. Zhen et al. ANALYTICAL BIOCHEMISTRY
- Inhibition of apelin expression switches endothelial cells from proliferative to mature state in pathological retinal angiogenesis
- (2013) Atsushi Kasai et al. ANGIOGENESIS
- Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline
- (2013) Paul E. Stevens ANNALS OF INTERNAL MEDICINE
- Structural features of the apelin receptor N-terminal tail and first transmembrane segment implicated in ligand binding and receptor trafficking
- (2013) David N. Langelaan et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Sustained Cardiovascular Actions of APJ Agonism During Renin–Angiotensin System Activation and in Patients With Heart Failure
- (2013) Gareth D. Barnes et al. Circulation-Heart Failure
- ELABELA: A Hormone Essential for Heart Development Signals via the Apelin Receptor
- (2013) Serene C. Chng et al. DEVELOPMENTAL CELL
- Tumour co-expression of apelin and its receptor is the basis of an autocrine loop involved in the growth of colon adenocarcinomas
- (2013) François-Xavier Picault et al. EUROPEAN JOURNAL OF CANCER
- An Abnormal Apelin/Vasopressin Balance May Contribute to Water Retention in Patients With the Syndrome of Inappropriate Antidiuretic Hormone (SIADH) and Heart Failure
- (2013) Anne Blanchard et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Apelin is a positive regulator of ACE2 in failing hearts
- (2013) Teruki Sato et al. JOURNAL OF CLINICAL INVESTIGATION
- Apelin inhibits the development of diabetic nephropathy by regulating histone acetylation in Akita mouse
- (2013) Hong Chen et al. JOURNAL OF PHYSIOLOGY-LONDON
- Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
- (2013) Ron T Gansevoort et al. LANCET
- Apelin and copeptin: Two opposite biomarkers associated with kidney function decline and cyst growth in autosomal dominant polycystic kidney disease
- (2013) Antonio Lacquaniti et al. PEPTIDES
- Post-infarct treatment with [Pyr1]-apelin-13 reduces myocardial damage through reduction of oxidative injury and nitric oxide enhancement in the rat model of myocardial infarction
- (2013) Yaser Azizi et al. PEPTIDES
- Promoting Effects of the Adipokine, Apelin, on Diabetic Nephropathy
- (2013) Bao-hai Zhang et al. PLoS One
- The Role of Apelin in the Retina of Diabetic Rats
- (2013) Qiang Lu et al. PLoS One
- Preferential apelin-13 production by the proprotein convertase PCSK3 is implicated in obesity
- (2013) Kyungsoo Shin et al. FEBS Open Bio
- Global Prevalence and Major Risk Factors of Diabetic Retinopathy
- (2012) J. W. Y. Yau et al. DIABETES CARE
- Apelin regulates the electrophysiological characteristics of atrial myocytes
- (2012) Chen-Chuan Cheng et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- APJ acts as a dual receptor in cardiac hypertrophy
- (2012) Maria Cecilia Scimia et al. NATURE
- Hypoxia-induced up-regulation of apelin is associated with a poor prognosis in oral squamous cell carcinoma patients
- (2012) Kyun Heo et al. ORAL ONCOLOGY
- Effects of apelin and leptin on renal functions following renal ischemia/reperfusion: An experimental study
- (2012) TAMER SAGIROGLU et al. Experimental and Therapeutic Medicine
- Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation
- (2011) G. Zhang et al. BLOOD
- Discovery of a Competitive Apelin Receptor (APJ) Antagonist
- (2011) N. J. Maximilian Macaluso et al. ChemMedChem
- Elucidation of the Structure-Activity Relationships of Apelin: Influence of Unnatural Amino Acids on Binding, Signaling, and Plasma Stability
- (2011) Alexandre Murza et al. ChemMedChem
- Non-activated APJ suppresses the angiotensin II type 1 receptor, whereas apelin-activated APJ acts conversely
- (2011) Xiao Sun et al. HYPERTENSION RESEARCH
- Apelin protects against angiotensin II-induced cardiovascular fibrosis and decreases plasminogen activator inhibitor type-1 production
- (2011) Khandaker Siddiquee et al. JOURNAL OF HYPERTENSION
- The contribution of chronic kidney disease to the global burden of major noncommunicable diseases
- (2011) William G. Couser et al. KIDNEY INTERNATIONAL
- Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans
- (2010) Cédric Dray et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The fate of the internalized apelin receptor is determined by different isoforms of apelin mediating differential interaction with β-arrestin
- (2010) Dennis K. Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Acute Cardiovascular Effects of Apelin in Humans
- (2010) A.G. Japp et al. CIRCULATION
- Effects of Olmesartan on Apelin/APJ and Akt/Endothelial Nitric Oxide Synthase Pathway in Dahl Rats With End-stage Heart Failure
- (2010) Hiromichi Fukushima et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Close bidirectional relationship between chronic kidney disease and atrial fibrillation: The Niigata preventive medicine study
- (2009) Hiroshi Watanabe et al. AMERICAN HEART JOURNAL
- Aortic PWV in Chronic Kidney Disease: A CRIC Ancillary Study
- (2009) Raymond R. Townsend et al. AMERICAN JOURNAL OF HYPERTENSION
- Hypertension Awareness, Treatment, and Control in Adults With CKD: Results From the Chronic Renal Insufficiency Cohort (CRIC) Study
- (2009) Paul Muntner et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Endogenous regulation of cardiovascular function by apelin-APJ
- (2009) David N. Charo et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Structural Insight into G-Protein Coupled Receptor Binding by Apelin†
- (2009) David N. Langelaan et al. BIOCHEMISTRY
- Prevalence of Atrial Fibrillation and Its Predictors in Nondialysis Patients with Chronic Kidney Disease
- (2009) W. Ananthapanyasut et al. Clinical Journal of the American Society of Nephrology
- [Pyr 1 ]Apelin-13 Identified as the Predominant Apelin Isoform in the Human Heart
- (2009) Janet J. Maguire et al. HYPERTENSION
- Apelin decreases the SR Ca2+ content but enhances the amplitude of [Ca2+]i transient and contractions during twitches in isolated rat cardiac myocytes
- (2008) Chen Wang et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Retardation of Retinal Vascular Development in Apelin-Deficient Mice
- (2008) Atsushi Kasai et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The apelin–APJ system in heart failure
- (2008) Alan G. Japp et al. BIOCHEMICAL PHARMACOLOGY
- Apelin Stimulates Glucose Utilization in Normal and Obese Insulin-Resistant Mice
- (2008) Cédric Dray et al. Cell Metabolism
- Hypoxia-Induced Apelin Expression Regulates Endothelial Cell Proliferation and Regenerative Angiogenesis
- (2008) Mélanie Eyries et al. CIRCULATION RESEARCH
- Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis
- (2008) Hiroyasu Kidoya et al. EMBO JOURNAL
- Vascular Effects of Apelin In Vivo in Man
- (2008) Alan G. Japp et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reciprocal Regulation of Plasma Apelin and Vasopressin by Osmotic Stimuli
- (2008) M. Azizi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of apelin on glomerular hemodynamic function in the rat kidney
- (2008) Annette Hus-Citharel et al. KIDNEY INTERNATIONAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started